Gerresheimer AG
Global provider of packaging and drug delivery systems for pharma, biotech, and cosmetics.
GXI | F
Overview
Corporate Details
- ISIN(s):
- DE000A0LD6E6
- LEI:
- 5299006GD4UWSYZOKC28
- Country:
- Germany
- Address:
- Klaus-Bungert-Straße 4, 40468 Düsseldorf
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Gerresheimer AG is a global partner and solutions provider specializing in primary packaging and drug delivery systems for the pharmaceutical, biotech, and cosmetics industries. The company develops and manufactures a broad portfolio of high-quality glass and plastic products, including pharmaceutical vials, syringes, ampoules, cartridges, and containers. It also offers integrated solutions for drug delivery devices, such as inhalers and auto-injectors, acting as a full-service partner from concept development to the finished product. Additionally, Gerresheimer provides packaging for the perfume and personal care sectors and serves as a supplier for diagnostic and medical device components.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-13 10:00 |
Regulatory News Service
Gerresheimer: FDA grants Approval of SQ Innovations Lasix ONYU*
|
English | 13.3 KB | ||
| 2025-10-10 00:00 |
Quarterly Report
Q3 statement / Q3 financial report 2024/2025
|
English | 338.4 KB | ||
| 2025-10-09 23:58 |
Earnings Release
Gerresheimer: Business performance and slower market growth require guidance ad…
|
English | 16.0 KB | ||
| 2025-10-09 10:29 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 19.1 KB | ||
| 2025-10-08 22:09 |
Earnings Release
Gerresheimer AG: Business performance and slower market growth require adjustme…
|
English | 8.1 KB | ||
| 2025-10-07 11:24 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.7 KB | ||
| 2025-10-06 09:48 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 19.1 KB | ||
| 2025-10-01 13:04 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 15.8 KB | ||
| 2025-09-26 09:31 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 16.2 KB | ||
| 2025-09-24 10:48 |
Legal Proceedings Report
Gerresheimer comments on the audit by German BaFin
|
English | 7.5 KB | ||
| 2025-09-18 09:16 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.9 KB | ||
| 2025-09-17 08:25 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 19.4 KB | ||
| 2025-09-15 11:07 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 15.8 KB | ||
| 2025-09-10 21:26 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 15.8 KB | ||
| 2025-09-08 23:44 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 19.4 KB |
Automate Your Workflow. Get a real-time feed of all Gerresheimer AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Gerresheimer AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-13 | Siemssen, Dietmar | Board | Buy | None | 74,994.10 EUR |
| 2022-10-14 | Siemssen, Dietmar | Board | Buy | None | 137,500.00 EUR |
| 2022-10-14 | Simon-Schröter, Dr Wolfram | Other | Buy | None | 2,958.00 EUR |
| 2022-09-19 | Abt, Andrea | Supervisory board | Buy | None | 25,075.00 EUR |
| 2022-09-19 | Empl, Andreas | Board | Buy | None | 1,820.00 EUR |
| 2022-07-18 | Siemssen, Dietmar | Board | Buy | None | 151,730.25 EUR |
| 2021-07-14 | Burkhardt, Dr. Lukas | Board | Buy | None | 181,357.60 EUR |
| 2021-07-14 | Siemssen, Dietmar | Board | Buy | None | 139,732.50 EUR |
